Adverse psychosocial factors predict poorer prognosis in HIV disease: A meta-analytic review of prospective investigations

Brain, Behavior, and Immunity

Volumn 23, Issue 4, 2009, Pages 434-445

  Chida, Yoichi ^a   Vedhara, Kavita ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Coping style; Depression and anxiety; Personality; Psychoneuroimmunology; Psychosocial stress; Social support

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVERSE OUTCOME; ANXIETY DISORDER; CD4+ T LYMPHOCYTE; COPING BEHAVIOR; DEPRESSION; DISEASE COURSE; DISTRESS SYNDROME; EMOTIONAL STRESS; HOPELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MEDLINE; MENTAL STRESS; MORTALITY; NEUROSIS; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; PSYCINFO; REVIEW; VIRUS LOAD;

ADAPTATION, PSYCHOLOGICAL; ADULT; DISEASE PROGRESSION; EMOTIONS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; PERSONALITY; PROGNOSIS; PROSPECTIVE STUDIES; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 63249099608     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.01.013     Document Type: Review

References (95)

1. *Anastos K., Schneider M.F., Gange S.J., Minkoff H., Greenblatt R.M., Feldman J., Levine A., Delapenha R., Cohen M., and the Women's Interagency HIV study collaborative group. The association of race, sociodemographic, and behavioral therapy in women. J. Acquir. Immune. Defic. Syndr. 39 (2005) 537-544
2. *Antelman G., Kaaya S., Wei R., Mbwambo J., Msamanga G.I., Fawzi W.W., and Smith Fawzi M.C. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J. Acquir. Immune. Defic. Syndr. 44 (2007) 470-477
3. Antoni M.H. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr. 8 (2003) 40-51
4. *Ashton E., Vosvick M., Chesney M., Gore-Felton C., Koopman C., O'Shea K., Maldonado J., Bachmann M.H., Israelski D., Flamm J., and Spiegel D. Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDS 19 (2005) 587-598
5. Balbin E.G., Ironson G.H., and Solomon G.F. Stress and coping: the psychoneuroimmunology of HIV/AIDS. Best Prac. Res. Clin. Endocrinol. Metab. 13 (1999) 615-633
6. *Bouhnik A.-D., Préau M., Vincent E., Carrieri M.P., Gallais H., Lepeu G., Gastaut J.-A., Moatti J.-P., Spire B., and the MANIF 2000 study group. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antiviral Ther. 10 (2005) 53-61
7. *Burgoyne R.W. Exploring direction of causation between social support and clinical outcome for HIV-positive adults in the context of highly active antiretroviral therapy. AIDS Care 17 (2005) 111-124
8. Capitanio J.P., Abel K., Mendoza S.P., Blozis S.A., McChesney M.B., Cole S.W., and Mason W.A. Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease. Brain Behav. Immun. 22 (2008) 676-689
9. Centers for Disease Control and Prevention, 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep. 1992 Dec 18, 41 (RR-17) 1-19. . (accessed 29.6.08.)
10. Chida Y., and Hamer M. Chronic psychosocial factors and acute physiological responses to laboratory induced stress in the healthy populations: a quantitative review of 30 years of investigations. Psychol. Bull. 134 (2008) 829-885
11. Chida Y., and Hamer M. An association of adverse psychosocial factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia 51 (2008) 2168-2178
12. Chida Y., Hamer M., and Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom. Med. 70 (2008) 102-116
13. Chida Y., Hamer M., Wardle J., and Steptoe A. Do psychosocial stress-related factors contribute to cancer incidence and survival?. Nat. Clin. Prac. Oncol. 5 (2008) 466-475
14. Chida Y., and Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom. Med. 70 (2008) 741-756
15. Cohen S., Janicki-Deverts D., and Miller G. Psychological stress and disease. JAMA 298 (2007) 1685-1687
16. Cohen J. Statistical Power Analysis For The Behavioral Sciences. second ed. (1988), Lawrence Erlbaum Associates, Hillsdale, NJ
17. Cole S.W. Psychosocial influences on HIV-1 disease progression: Neural, endocrine, and virologic mechanisms. Psychosom. Med. 70 (2008) 562-568
18. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., and Zack J.A. Impaired response to HAART in HIV-infected individual with high autonomic nervous system activity. Proc. Natl. Acad. Sci. USA 98 (2001) 12695-12700
19. Cole S.W., Jamieson B.D., and Zack J.A. cAMP externalizes lymphocyte CXCR4: implications for chemotaxis and HIV infection. J. Immunol. 162 (1999) 1392-1400
20. Cole S.W., Korin W.D., Fahey J.L., and Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161 (1998) 610-616
21. *Cole S.W., Kemeny M.E., Taylor S.E., Visscher B.R., and Fahey J. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom. Med. 58 (1996) 219-231
22. Collado-Hidalgo A., Sung C., and Cole S. Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav. Immun. 20 (2006) 552-563
23. *Cook J.A., Grey D., Burke J., Cohen M.H., Gurtman A.C., Richardson J.L., Wilson T.E., Young M.A., and Hessol N.A. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am. J. Public Health 94 (2004) 1133-1140
24. Crepaz N., Passin W.F., Herbst J.H., Rama S.M., Malow R.M., Purcell D.W., and Wolitski R.J. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychol. 27 (2008) 4-14
25. Cruess D.G., Petitto J.M., Leserman J., Douglas S.D., Gettes D.R., Ten Have T.R., and Evans D.L. Depression and HIV infection: impact on immune function and disease progression. CNS Spectr. 8 (2003) 52-58
26. Dersimonian R., and Laird N. Metaanalysis in clinical-trials. Control Clin. Trials 7 (1986) 177-188
27. Ebmeier K.P., Donaghey C., and Steele J.D. Recent development and current controversies in depression. Lancet 367 (2006) 153-167
28. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
29. Evans D.L., Ten Have T.R., Douglas S.D., Gettes D.R., Morrison M., Chiappini M.S., et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am. J. Psychiatry 159 (2002) 1752-1759
30. *Farinpour R., Miller E.N., Satz P., Selnes O.A., Cohen B.A., Becker J.T., Skolasky R.L., and Visscher B.R. Psychosocial risk factors of HIV morbidity and mortality: findings from the multicenter AIDS cohort study (MACS). J. Clin. Experment. Neuropsychol. 25 (2003) 654-670
31. Glaser R., Rabin B., Chesney M., Cohen S., and Natelson B. Stress-induced immunomodulation. Implications for infectious diseases?. JAMA 281 (1999) 2268-2270
32. *Golub E.T., Astemborski J.A., Hoover D.R., Anthony J.C., Vlahov D., and Strathdee S.A. Psychological distress and progression to AIDS in a cohort of injection drug users. J. Acquir. Immune. Defic. Syndr. 32 (2003) 429-434
33. Gore-Felton C., and Koopman C. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosom. Med. 70 (2008) 569-574
34. Graham J.E., Christian L.M., and Kiecolt-Glaser J.K. Close relationships and immunity. In: Ader R. (Ed). Psychoneuroimmunology (2007), Academic Press, Amsterdam 781-798
35. Greeson J.M., Hurwitz B.E., Llabre M.M., Schneiderman N., Penedo F.J., and Klimas N.G. Psychological distress, killer lymphocytes and disease severity in HIV/AIDS. Brain Behav. Immun. 22 (2008) 901-911
36. *Howland L.C., Gortmaker S.L., Mofenson L.M., Spino C., Gardner J.D., Gorski H., Fowler M.G., and Oleske J. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics 106 (2000) 540-546
37. *Ickovics J.R., Hamburger M.E., Vlahov D., Schoenbaum E.E., Schuman P., Boland R.J., Moore J., and HIV epidemiology research study group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 285 (2001) 1466-1474
38. *Ironson G.H., O'Cleirigh C., Weiss A., Schneiderman N., and Costa P.T. Personality and HIV disease progression: role of NEO-PI-R openness, extraversion, and profiles of engagement. Psychosom. Med. 70 (2008) 245-253
39. *Ironson G., O'Cleirigh C., Fletcher M.A., Laurenceau J.P., Balbin E., Klimas N., Schneiderman N., and Solomon G. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom. Med. 67 (2005) 1013-1021
40. *Ironson G., Friedman A., Klimas N., Antoni M., Fletcher A., LaPerriere A., Simoneau J., and Schneiderman N. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int. J. Behav. Med. 1 (1994) 90-105
41. Ironson G., and Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom. Med. 70 (2008) 546-554
42. Iyengar S., and Greenhouse J.B. Selection models and the file drawer problem. Stat. Sci. 3 (1988) 109-135
43. Joint United Nations Programme on HIV/AIDS, 2006. Overview of the global AIDS epidemic. 2006 report on the global AIDS epidemic. . (accessed 29.06.08).
44. *Kemeny M.E., and Dean L. Effects of AIDS-related bereavement on HIV progression among New York city gay men. AIDS Educ. Prev. 7 (1995) 36-47
45. *Kessler R.C., Foster C., Joseph J., Ostrow D., Wortman C., Phair J., and Chmiel J. Stressful life events and symptom onset in HIV infection. Am. J. Psychiatry 148 (1991) 733-738
46. *Kimerling R., Calhoun K.S., Forehand R., Armistead L., Morse E., Morse P., Clark R., and Clark L. AIDS Educ. Prev. 11 (1999) 321-330
47. Kino T., Kopp J.B., and Chrousos G.P. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediate fashion: direct protective effects at variance with clinical phenomenology. J. Steroid. Boichem. Mol. Biol. 75 (2000) 283-290
48. Kopnisky K.L., Stoff D.M., and Rausch D.M. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav. Immun. 18 (2004) 246-261
49. Laupacis A., Wells G., Richardson S., and Tugwell P. Users' guides to the medical literature. V. How to use an article about prognosis. JAMA 272 (1994) 234-237
50. LeLorier J., Gregoire G., Benhaddad A., Lapierre J., and Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N. Engl. J. Med. 337 (1997) 536-542
51. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom. Med. 70 (2008) 539-545
52. *Leserman J., Pence B.W., Whetten K., Mugavero M.J., Thielman N.M., Swartz M.S., and Stangl D. Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am. J. Psychiatry 164 (2007) 1707-1713
53. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol. Psychiatry 54 (2003) 295-306
54. *Leserman J., Petitto J.M., Gu H., Gaynes B.N., Barroso J., Golden R.N., Perkins D.O., Folds J.D., and Evans D.L. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol. Med. 32 (2002) 1059-1073
55. *Leserman J., Petitto J.M., Golden R.N., Gaynes B.N., Gu H., Perkins D.O., Silva S.G., Folds J.D., and Evans D.L. Impact of stressful life events, depression, social support, and cortisol on progression to AIDS. Am. J. Psychiatry 157 (2000) 1221-1228
56. Markham P., Salahuddin S., Veren K., Orndorff S., and Gallo R. Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int. J. Cancer 37 (1986) 67-72
57. Masui, K., 2003. Meta-analysis software User's Guide. In: Masui, K. (Ed.), Kokokara-hajimeru Meta-analysis, Shinko-Koueki Medical Press, Tokyo, pp. 91-121.
58. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338 (1998) 171-179
59. Miller G.E., and Cole S.W. Social relationships and the progression of human immunodeficiency virus infection: a review of evidence and possible underlying mechanisms. Ann. Behav. Med. 20 (1998) 181-189
60. Mills E.J., Kelly S., Bradley M., Mollon P., Cooper C., and Nachega J. Antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or death: A meta-regression analysis. HIV Med. 9 (2008) 849-857
61. *Mulder C.L., Antoni M.H., Duivenvoorden H.J., Kauffmann R.H., and Goodkin K. Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J. Psychosom. Res. 39 (1995) 957-965
62. Nott K.H., Vedhara K., and Spickett G.P. Psychology, immunity, and HIV. Psychoneuroendocrinology 20 (1995) 451-474
63. Overton R.C. A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests of moderator variable effects. Psychol. Med. 3 (1998) 354-379
64. *Page-Shafer K., Delorenze G.N., Satariano W.A., and Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco men's health survey. Ann. Epidemiol. 6 (1996) 420-430
65. *Patterson T.L., Shaw W.S., Semple S.J., Cherner M., McCutchan J.A., Stkinson J.H., Grant I., Nannis E., and HIV neurobehavioral research center group. Relationship of psychosocial factors to HIV disease progression. Ann. Behav. Med. 18 (1996) 30-39
66. *Pence B.W., Miller W.C., Gaynes B.N., and Eron J.J. Psychiatric illness and virologic response in patients initiating highly active antiviral therapy. J. Acquir. Immune. Defic. Syndr. 44 (2007) 159-166
67. *Perry S., Fishman B., Jacobsberg L., and Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch. Gen. Psychiatry 49 (1992) 396-401
68. *Persson L., Östergren P.-O., Hanson B.S., Lindgren A., and Naucler A. Social network, social support and the rate of decline of CD4 lymphocytes in asymptomatic HIV-positive homosexual men. Scand. J. Public Health 30 (2002) 184-190
69. Pressman S.D., and Cohen S. Does positive affect influence health?. Psychol. Bull. 131 (2005) 925-971
70. *Rabkin J.G., Williams J.B.W., Remien R.H., Goetz R., Kertzner R., and Gorman J.M. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch. Gen. Psychiatry 48 (1991) 111-119
71. *Remor E., Penedo F.J., Shen B.-J., and Shneiderman N. Perceived stress is associated with CD4+ cell decline in men and women living with HIV/AIDS in Spain. AIDS Care 19 (2007) 215-219
72. Robles T.F., Glaser R., and Kiecolt-Glaser J.K. Out of balance: a new look at chronic stress, depression, and immunity. Curr. Dir. Psychol. Sci. 14 (2005) 111-115
73. equivalent: a simple effect size indicator. Psychol. Method 8 (2003) 492-496
74. Rosenthal R., and DiMatteo M.R. Meta-analysis: recent developments in quantitative methods for literature reviews. Annu. Rev. Psychol. 52 (2001) 59-82
75. Rosenthal R. Meta-Analytic Procedure For Social Research. second ed. (1991), Sage, Newbury Park, CA
76. Scargle J.D. Publication bias: the "file-drawer" problem in scientific inference. J. Sci. Explor. 14 (2000) 91-106
77. Scott-Sheldon L.A.J., Kalichman S.C., Carey M.P., and Fielder R.L. Stress management interventions for HIV+ adults: A meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 27 (2008) 129-139
78. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
79. Sloan E.K., Collado-Hidalgo A., and Cole S.W. Psychobiology of HIV infection. In: Ader R. (Ed). Psychoneuroimmunology (2007), Academic Press, Amsterdam 1053-1076
80. *Solano L., Costa M., Temoshok L., Salvati S., Coda R., Aiuti F., Di Sora F., D'Offizi G., Figa-Talamanca L., Mezzaroma I., Montella F., and Bertini M. An emotionally inexpressive (Type C) coping style influences HIV disease progression at six and twelve month follow-ups. Health Psychol. 17 (2002) 641-655
81. *Solano L., Costa M., Salvati S., Coda R., Aiuti F., Mezzaroma I., and Bertini M. Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study. J. Psychosom. Res. 37 (1993) 39-51
82. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., and Thacker S.B. Meta-analysis of observational studies in epidemiology. JAMA 283 (2000) 2008-2012
83. Taylor S.E., Klein L.C., Lewis B.P., Gruenewald T.L., Gurung R.A., and Updegraff J.A. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol. Rev. 107 (2000) 411-429
84. Temoshok L.R., Wald R.L., Synowski S., and Garzino-Demo A. Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression. Psychosom. Med. 70 (2008) 555-561
85. Temoshok L.R., Waldstein S.R., Wald R.L., Garzino-Demo A., Synowski S.J., Sun L., and Wiley J.A. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain Behav. Immun. 22 (2008) 781-792
86. *Theorell T., Blomkvist V., Jonnsonn H., Schulman S., Berntorp E., and Stigendal L. Social support and the development of immune function in human immunodeficiency virus infection. Psychosom. Med. 57 (1995) 32-36
87. *Thornton S., Troop M., Burgess A.P., Button J., Goodall R., Flynn R., Gazzard B.G., Catalán J., and Easterbrook P.J. The relationship of psychological variables and disease progression among long-term HIV-infected men. Int. J. STD AIDS 11 (2000) 734-742
88. *Vassend O., Eskild A., and Halvorsen R. Negative affectivity, coping, immune status, and disease progression in HIV infected individuals. Psychol. Health 12 (1997) 375-388
89. *Vedhara K., Schifitto G., McDermott M., and the Dana consortium on therapy for HIV dementia and related cognitive disorders. Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Behav. Med. 25 (1999) 43-47
90. *Vedhara K., Nott K.H., Bradbeer C.S., Davidson E.A.F., Ong E.L.C., Snow M.H., Palmer D., and Nayagam A.T. Greater emotional distress is associated with accelerated CD4+ cell decline in HIV infection. J. Psychosom. Res. 42 (1997) 379-390
91. *Villes V., Spire B., Lewden C., Perronne C., Besnier J.-M., Garré M., Chene G., Leport C., Carrieri M.P., Moing V.L., and the ANRS CO-8 APROCO-COPILOTE study group. The effect of depressive syndromes at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antiviral Ther. 12 (2007) 1067-1074
92. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., and Vandenbroucke J.P. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann. Intern. Med. 147 (2007) 573-577
93. World Health Organization, 2005 Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS case definitions for Surveillance. 2005. . (accessed 29.06.08).
94. *Young J., De Geest S., Spirig R., Flepp M., Richenback M., Furrer H., Bernasconi E., Hirschel B., Telenti A., Vernazza P., Battergay M., and Bucher H.C. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ 328 (2004) 15 10.1136/bmj.328.7430.15
95. Zorrilla E.P., McKay J.R., Luborsky L., and Schmidt K. Relation of stressors and depressive symptoms to clinical progression of viral illness. Am. J. Psychiatry 153 (1996) 626-635